Research

WellAir technology has been proven safe and effective in more than 50 laboratory and clinical studies. Our products are trusted by hundreds of hospitals and senior living facilities round the world.

Summary of the dozens of independent laboratory tests carried out on Novaerus technology.

Viruses

Name	Reduction.	Time	Space	Model
SARS-CoV-2	99.99%	15 min	16 m³	NV1050
Measles	99.87%	20-30 min	28.5 m³	NV1050
Influenza A	99.9%	10-20 min	28.5 m³	NV1050
Phi X 174	98.8%	30 min	60 m³	NV1050
SARS-CoV-2	99.99%	5 hours	16 m³	NV900
Influenza A	99.99%	5 hours	16 m³	NV900
Norovirus	99.99%	5 hours	16 m³	NV900

Bacteria

Name	Reduction.	Time	Space	Model
Tuberculosis	97%	30 min	30 m³	NV1050
Clostridicum difficile spores	99.9%	40 min	28.5 m³	NV1050
Staphylococcus epidermidis	99.9%	60 min	60 m³	NV1050
Escherichia coli	71.80%	5 min	2.3 m³	NV200
MRSA	99.94%	15 min	30 m³	NV1050
MRSA	99.99%	4 hours	1 m³	NV900
Bacillus subtilis	86.63%	6 hours	16 m³	NV900

Mold Spores

Name	Reduction.	Time	Space	Model
Aspergillus niger	99.99%	30 min	16 m³	NV1050
Aspergillus niger	99.10%	4 hours	16 m³	NV900

VOCs

Name	Reduction.	Time	Space	Model
Toluene	99%	9.1 min	19.72 m³	NV1050
Formaldehyde	99.68%	1.1 min	16 m³	NV1050
Nitrogen Dioxide	99.49%	7.2 min	16 m³	NV1050

Particulate

Name	Reduction.	Time	Space	Model
PM 1	99%	6.33 min	19.72 m³	NV1050
PM 2.5	99%	6.26 min	19.72 m³	NV1050

Meadow View Case Study

This 24-month study compares the total number of nosocomial respiratory infections before and after implementation of the Novaerus technology.

Full Report
No results
No results

CONTACT US

USA Headquarters
Stamford, CT 06902
Call: 1 866 508 1118 Email: info@wellairsolutions.com

Ireland Headquarters
DCU Innovation Campus Old Finglas Road Glasnevin, Dublin 11
Call: +353 1 907 2750 Email: info@wellairsolutions.com